Home › Brain and Spinal Cord Tumors › California › Los Angeles
Brain and Spinal Cord Tumors clinical trials in Los Angeles, CA
6 studies for Brain and Spinal Cord Tumors are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of PHST001 in Advanced Solid Tumors
RecruitingPhase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
- University of Southern California, Los Angeles
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
RecruitingPhase 1/2
- Cedars-Sinai Medical Center, Los Angeles
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RecruitingPhase 1/2
- California Research Institute, Los Angeles
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Children's Hospital Los Angeles, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Mattel Children's Hospital UCLA, Los Angeles
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
RecruitingPhase 2
- Children's Hospital Los Angeles, Los Angeles
Brain and Spinal Cord Tumors trials in other cities
- New York City, NY10 studies
- Houston, TX9 studies
- Boston, MA7 studies
- Nashville, TN7 studies
- Philadelphia, PA7 studies
- Washington, DC6 studies
- Dallas, TX5 studies
- Seattle, WA5 studies
- Chicago, IL5 studies
- Columbus, OH5 studies
- Atlanta, GA5 studies
- Mountain View, CA5 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.